The Relative Strength (RS) Rating for Alphatec Holdings jumped into a new percentile Wednesday, with an increase from 77 to 82.
IBD's unique RS Rating identifies technical performance by using a 1 (worst) to 99 (best) score that indicates how a stock's price performance over the trailing 52 weeks matches up against the rest of the market.
History shows that the stocks that go on to make the biggest gains typically have an RS Rating north of 80 in the early stages of their moves.
Hone Your Stock-Picking Skills By Focusing On These Factors
Now is not an ideal time to jump in since it isn't near a proper buy zone, but see if the stock goes on to offer and clear a proper buy point.
The company showed 0% earnings growth in the latest quarterly report, while sales growth came in at 27%. Keep an eye out for the company's next round of numbers on or around Feb. 26.
The company holds the No. 45 rank among its peers in the Medical-Products industry group. Boston Scientific, Globus Medical and Insulet are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
